Your browser doesn't support javascript.
loading
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation.
Mabuchi, Hiroshi; Nohara, Atsushi; Noguchi, Tohru; Kobayashi, Junji; Kawashiri, Masa-aki; Inoue, Takeshi; Mori, Mika; Tada, Hayato; Nakanishi, Chiaki; Yagi, Kunimasa; Yamagishi, Masakazu; Ueda, Kousei; Takegoshi, Tadayoshi; Miyamoto, Susumu; Inazu, Akihiro; Koizumi, Junji.
Afiliación
  • Mabuchi H; Department of Lipidology, Graduate School of Medical Science, Kanazawa University, Takara-machi 13-1, Kanazawa 920-8640, Japan. Electronic address: mabuchi@med.kanazawa-u.ac.jp.
  • Nohara A; Department of Lipidology, Graduate School of Medical Science, Kanazawa University, Takara-machi 13-1, Kanazawa 920-8640, Japan.
  • Noguchi T; Department of Lipidology, Graduate School of Medical Science, Kanazawa University, Takara-machi 13-1, Kanazawa 920-8640, Japan.
  • Kobayashi J; Department of Lipidology, Graduate School of Medical Science, Kanazawa University, Takara-machi 13-1, Kanazawa 920-8640, Japan.
  • Kawashiri MA; Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Inoue T; Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Mori M; Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Tada H; Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Nakanishi C; Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Yagi K; Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Yamagishi M; Division of Cardiovascular Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
  • Ueda K; Komatsu Municipal Hospital, Komatsu, Japan.
  • Takegoshi T; Fukui Prefectural Hospital, Fukui, Japan.
  • Miyamoto S; Hokuriku Central Hospital, Oyabe, Japan.
  • Inazu A; Laboratory Science, Graduate School of Medical Science, Kanazawa University, Japan.
  • Koizumi J; General Medicine, Graduate School of Medical Science, Kanazawa University, Japan.
Atherosclerosis ; 236(1): 54-61, 2014 Sep.
Article en En | MEDLINE | ID: mdl-25014035
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Serina Endopeptidasas / Proproteína Convertasas / Hiperlipoproteinemia Tipo II Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Atherosclerosis Año: 2014 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Serina Endopeptidasas / Proproteína Convertasas / Hiperlipoproteinemia Tipo II Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Atherosclerosis Año: 2014 Tipo del documento: Article Pais de publicación: Irlanda